Bayer shareholders approve capital increase

Almost seven years after the disastrous Monsanto takeover, Bayer is still standing with its back to the wall because of the glyphosate cracks. Chief Bill Anderson is slowly running out of time. Now he wants to create new room for manoeuvre.

At the Bayer chemical company, there is still no solution in sight in the glyphosate wave. Chief Executive Officer Bill Anderson is guilty of the expected liberation strike just two years after taking office. Now there is a new proposal.

The Bayer Group is in crisis because of glyphosate legal disputes. The company has asked its shareholders for permission to obtain new capital if necessary - with success. By David Zajonz.

Prosecutions related to Roundup lead to the financial results of the German group.

The Annual General Meeting of Bayer-AG shows the construction sites of the Group: possible capital increase, bureaucratic hurdles and the question of investors: What about Monsanto?

Bayer n'exclut pas de renoncer au glyphosate

Le chimiste allemand Bayer s'est interrogé vendredi sur le futur de la production de son herbicide controversé à base de glyphosate, toujours ciblé par une avalanche de procès, lors de son assemblée générale annuelle marquée par la nervosité des actionnaires.